Summary Landsteiner Scientific, S.A. de C.V. (Landsteiner Scientific) is a pharmaceutical company. The company develops, manufactures, distributes and commercializes healthcare products. Its product categories include specialty, OTC and therapeutic areas. The company’s products include Serax, Promezal, Xintilan, Hofodilan, Didasten, Zonilan, Xintilan, HHT, Xerfelan, Vigam, and Optivate, among others. Landsteiner Scientific supplies drugs for the treatment in the areas of cardiology, oncology, gynecology, infectious HIV/AIDS, transplants, urology, gastroenterology, hematology, endocrinology, internal medicine, nephrology and neurology. The company has presence in North Carolina, the US; and Toluca, Monterrey, and Guadalajara in Mexico. Landsteiner Scientific is headquartered in Pedregal, Mexico. Landsteiner Scientific, S.A. de C.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal... Research Beam Model: Research Beam Product ID: 190957 250 USD New
Landsteiner Scientific, S.A. de C.V. - Pharmaceuticals and Healthcare - Deals and Alliances Profile
 
 

Landsteiner Scientific, S.A. de C.V. - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : November   2014
  • Pages : 15
  • Publisher : GlobalData
 
 
 
Summary

Landsteiner Scientific, S.A. de C.V. (Landsteiner Scientific) is a pharmaceutical company. The company develops, manufactures, distributes and commercializes healthcare products. Its product categories include specialty, OTC and therapeutic areas. The company’s products include Serax, Promezal, Xintilan, Hofodilan, Didasten, Zonilan, Xintilan, HHT, Xerfelan, Vigam, and Optivate, among others. Landsteiner Scientific supplies drugs for the treatment in the areas of cardiology, oncology, gynecology, infectious HIV/AIDS, transplants, urology, gastroenterology, hematology, endocrinology, internal medicine, nephrology and neurology. The company has presence in North Carolina, the US; and Toluca, Monterrey, and Guadalajara in Mexico. Landsteiner Scientific is headquartered in Pedregal, Mexico.

Landsteiner Scientific, S.A. de C.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 6
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 8
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 10
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Imagina Tu Crecimiento Acquires 27.51% Stake In Landsteiner Scientific From Sinca Inbursa 11
Sinca Inbursa Acquires 25% Stake In Landsteiner Scientific 12
Licensing Agreements 13
Iroko Pharma Enters into Licensing Agreement with Landsteiner Scientific for Zorvolex 13
Landsteiner Scientific, S.A. de C.V. - Key Competitors 14
Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15
List Of Tables
List of Tables
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Key Facts 1
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 6
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Landsteiner Scientific, S.A. de C.V., Deals By Therapy Area, 2008 to YTD 2014 8
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 10
Imagina Tu Crecimiento Acquires 27.51% Stake In Landsteiner Scientific From Sinca Inbursa 11
Sinca Inbursa Acquires 25% Stake In Landsteiner Scientific 12
Iroko Pharma Enters into Licensing Agreement with Landsteiner Scientific for Zorvolex 13
Landsteiner Scientific, S.A. de C.V., Key Competitors 14
Landsteiner Scientific, S.A. de C.V., Other Locations 14
List Of Figures
List of Figures
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 1
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 1
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 1
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 1
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 6
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Landsteiner Scientific, S.A. de C.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter